当前位置：
X-MOL 学术
›
Blood Cancer J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2024-08-23 , DOI: 10.1038/s41408-024-01127-2 Jialing Lu 1 , Xiebing Bao 2 , Jihao Zhou 3 , Xiaoli Li 4 , Zhewei He 2 , Yujie Ji 2 , Shengli Xue 2 , Suning Chen 2 , Depei Wu 2 , Qi Hu 1 , Peng Ke 3 , Xiao Ma 2
中文翻译：
blinatumomab 作为 B 细胞急性淋巴细胞白血病移植桥梁的安全性和有效性，首次完全缓解且未检测到微小残留病灶
更新日期：2024-08-23
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2024-08-23 , DOI: 10.1038/s41408-024-01127-2 Jialing Lu 1 , Xiebing Bao 2 , Jihao Zhou 3 , Xiaoli Li 4 , Zhewei He 2 , Yujie Ji 2 , Shengli Xue 2 , Suning Chen 2 , Depei Wu 2 , Qi Hu 1 , Peng Ke 3 , Xiao Ma 2
Affiliation
|
中文翻译：
blinatumomab 作为 B 细胞急性淋巴细胞白血病移植桥梁的安全性和有效性，首次完全缓解且未检测到微小残留病灶
京公网安备 11010802027423号